MME and hydrops fetalis: It is unknown which of the several neprilysin substrates such as physiologically active natriuretic peptides, adrenomedullin, endothelin, angiotensin II, or a mix of substrates is responsible for the reported benefits. The pathophysiologic heterogeneity of the illness is a significant barrier impeding the discovery of new treatments for HF.